Dale Boursaw
Lake Havasu City, AZ (USA)
Role(s):
Founder/Owner/Principal
Precision Diagnostics, Inc.
Find More Startups
Startup
Location:
Lake Havasu City
Industry:
Healthcare
Year Founded:
2008
Number Employees:
1-10 people
Description:
Precision Diagnostics, Inc. is a service company providing invaluable diagnostic studies, interpretations, and reports to physicians requiring additional information on complex cases. We provide only the highest qualified electrodiagnostic technicians to conduct studies needed to allow physicians to properly diagnose life threatening diseases and illnesses. Studies will be performed based on the primary physician’s request , to include, but not limited to; NCV (Nerve Conduction Velocity), BAER (Brainstem Evoked Potential), VEP (Visually Evoked Potential), and Vascular studies. Precision Diagnostics, Inc. performs all studies in the confines of the requesting physician’s location. This allows the physician to oversee any and all tests performed by our technician and provides patients with the comfort and convenience verses travel to an outpatient lab. Once all required studies are completed by the technician, patient history and test results are electronically forwarded to a contracted neurologist for analysis and interpretations. The neurologist provides a detailed ROF ( Report of Findings) and recommendations for each test performed, on each patient. This information is forwarded to the primary physician. A consultation, by the provider, further treatment, and referrals for each patient is then discussed.
The market for Precision Diagnostics, Inc. is unrestricted and growing at the same time. What this means is, the demand is such that physicians and patients, spanning across the globe, can benefit from the services provided . Patients are referred for electrodiagnostic studies by neurologists, physiatrists trained in neuromuscular diagnosis, internists, primary care physicians, neurological and orthopedic surgeons, and other healthcare providers, such as chiropractors. There are approximately 80,000 chiropractors in the United States and Canada. Approximately 2,000 new graduates enter the field each year. An estimated 20,000,000 Americans are expected to visit a chiropractor each year. The aging of the population, continued population growth, advanced chiropractic treatments, increased health care, and greater health consciousness are trends that assure the diagnostic industry a future of expanding services. Precision Diagnostics, Inc. has multiple business partnerships in several states, within the chiropractic community. One of four company founders, Dr. Alan Meyer D.C. has numerous associations with other doctors of chiropractic country wide.
Precision Diagnostics, Inc. processes all claims to insurance carriers. Initially, all patients are 100% pre-approved by the patients healthcare insurance. Doctor‘s Access medical software will be utilized in maintaining patient files, claims, and schedules. Mr. Dale Boursaw, one of the company’s founders, is an executive board member with this software company. We will be utilizing Web M.D. as our clearing house for all electronic billing. Web M.D. is the worlds largest clearing house and has the #1 success rate of claims processed and received. Precision Diagnostics, Inc. is led by experienced physicians, management, and consultants as partners and executive board members. Based on research and business alliances previously formed, Precision Diagnostics, Inc. has selected Omaha, Nebraska as our first market on November 17, 2008. Las Vegas, Nevada will follow and Precision Diagnostics, Inc. will be fully operational on February 16, 2009. Seattle, Washington is scheduled for May 18, 2009 and Portland, Oregon on August 17, 2009. Each and every 3 months a new major metropolitan market will be added. Financials, based on extremely conservative growth, upper and lower NCV studies only, a revenue of $1.6 million for the first year. With upper and lower NCV, Baer/Vep, and Vascular studies performed, total revenue is increased by 78.8 % resulting in $2.03 million for the first year.